A carregar...

Development of Neuropeptide Drugs that Cross the Blood-Brain Barrier

Summary: In recent years, there have been several important advancements in the development of neuropeptide therapeutics. Nevertheless, the targeting of peptide drugs to the CNS remains a formidable obstacle. Delivery of peptide drugs is limited by their poor bioavailability to the brain due to low...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Egleton, Richard D., Davis, Thomas P.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society for Experimental NeuroTherapeutics, Inc. 2005
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC539319/
https://ncbi.nlm.nih.gov/pubmed/15717056
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!